,
Bowman, Emily R. http://orcid.org/0000-0003-1783-0361
Kulkarni, Manjusha
Gabriel, Janelle
Mo, Xiaokui
Klamer, Brett
Belury, Martha
Lake, Jordan E.
Zidar, David
Sieg, Scott F.
Mehta, Nehal N.
Playford, Martin P.
Kuritzkes, Daniel R.
Andrade, Adriana
Schmidt, Elizabeth Koss
Taylor, Christopher
Overton, Edgar T.
Willig, Amanda L.
Lederman, Michael M.
Funderburg, Nicholas T.
Funding for this research was provided by:
National Institutes of Health (R00HL108743, R56HL126563, R01HL134544, AI-07164, K23 AI110532, UM1 AI068634)
Article History
Received: 25 September 2020
Accepted: 26 November 2020
First Online: 7 December 2020
Ethics approval and consent to participate
: This study was approved by the institutional review boards at all participating sites, and is registered with Clinicaltrials.gov (NCT00660972). All study participants provided written informed consent.
: Consent form available upon request.
: NTF has served as a consultant for Gilead. MML have received grant support from Gilead. JEL has served as a consultant for Gilead and Merck, and received research support from Gilead.